Lantheus Holdings (LNTH) Amortization of Deferred Charges (2016 - 2026)
Lantheus Holdings (LNTH) reported Amortization of Deferred Charges of $1.1 million for Q1 2026, little changed year-over-year from $1.1 million in Q1 2025, and little changed quarter-over-quarter from $1.1 million in Q4 2025.
Lantheus Holdings (LNTH) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 11 years of Amortization of Deferred Charges data on file, last reported at $1.1 million in Q1 2026.
- Amortization of Deferred Charges for Q1 2026 came in at $1.1 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.5 million (up 2.74% YoY), and the FY2025 annual result was $4.5 million, up 3.75% from the prior year.
- Amortization of Deferred Charges was little changed at $1.1 million in Q1 2026 per LNTH's latest filing, from $1.1 million in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $1.1 million in Q1 2025 and troughed at $245000.0 in Q2 2022.
- A 5-year average of $906882.4 and a median of $1.1 million in 2023 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2022 and 2024: Amortization of Deferred Charges jumped 503.28% in 2022, then retreated 0.83% in 2024.
- A 5-year view of Amortization of Deferred Charges shows it stood at $512000.0 in 2022, then surged by 109.57% to $1.1 million in 2023, then climbed by 0.56% to $1.1 million in 2024, then climbed by 3.24% to $1.1 million in 2025, then rose by 0.09% to $1.1 million in 2026.
- Business Quant data shows LNTH's Amortization of Deferred Charges at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 1.07 Mn |
| Dec 31, 2023 | 1.07 Mn |